Cargando…
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome
Declared as a global public health emergency, coronavirus disease 2019 (COVID-19) is presented as a disease of the respiratory tract, although severe cases can affect the entire organism. Several studies have shown neurological symptoms, ranging from dizziness and loss of consciousness to cerebrovas...
Autores principales: | Simões, Júlia Leão Batista, Bagatini, Margarete Dulce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813171/ https://www.ncbi.nlm.nih.gov/pubmed/33462776 http://dx.doi.org/10.1007/s11481-020-09980-1 |
Ejemplares similares
-
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021) -
Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19
por: Simões, Júlia Leão Batista, et al.
Publicado: (2022) -
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
por: dos Anjos, Fernanda, et al.
Publicado: (2020) -
Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022) -
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
por: Leão Batista Simões, Júlia, et al.
Publicado: (2021)